awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q37239278-D9D0A5E8-048A-4A7B-B1BA-3D60C4502B1C
Q37239278-D9D0A5E8-048A-4A7B-B1BA-3D60C4502B1C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37239278-D9D0A5E8-048A-4A7B-B1BA-3D60C4502B1C
Population Pharmacokinetics and Exposure-Response (Efficacy and Safety/Tolerability) of Empagliflozin in Patients with Type 2 Diabetes.
P2860
Q37239278-D9D0A5E8-048A-4A7B-B1BA-3D60C4502B1C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37239278-D9D0A5E8-048A-4A7B-B1BA-3D60C4502B1C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
fb96e137ff4f34dd00944041b060cc34527e2a6c
P2860
Empagliflozin as add-on to metformin in patients with type 2 diabetes: a 24-week, randomized, double-blind, placebo-controlled trial.